{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@year": "2023",
                "@timestamp": "2023-07-07T08:25:42.000042-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "IDDI"},
                {"xocs:funding-agency-matched-string": "Ken Shain"},
                {"xocs:funding-agency-matched-string": "Levine Cancer Institute"},
                {"xocs:funding-agency-matched-string": "Secura Bio"},
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency-acronym": "NPC",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008272",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-16T02:52:42.163Z",
            "xocs:funding-text": [
                {"$": "This study was sponsored by Novartis Pharmaceuticals and Secura Bio. We thank all patients who participated in the study; the investigators and research staff in participating institutions; members of the independent review committee, Peter Voorhees (Levine Cancer Institute, Charlotte, NC, USA), Hani Hassoun (Memorial Sloan Kettering Cancer Center, New York, USA), and Ken Shain (Moffitt Cancer Center, Tampa, FL, USA); and Marc Buyse, of IDDI, for biostatistics support. Medical writing support was provided by Jessica Woods and Cara Valvona of Watermeadow Medical, part of Ashfield Healthcare, Witney, UK, funded by Secura Bio, San Diego, CA, USA, in accordance with Good Publication Practice guidelines."},
                {"$": "This study was sponsored by Novartis Pharmaceuticals and Secura Bio. We thank all patients who participated in the study; the investigators and research staff in participating institutions; members of the independent review committee, Peter Voorhees (Levine Cancer Institute, Charlotte, NC, USA), Hani Hassoun (Memorial Sloan Kettering Cancer Center, New York, USA), and Ken Shain (Moffitt Cancer Center, Tampa, FL, USA); and Marc Buyse, of IDDI, for biostatistics support. Medical writing support was provided by Jessica Woods and Cara Valvona of Watermeadow Medical, part of Ashfield Healthcare, Witney, UK, funded by Secura Bio, San Diego, CA, USA, in accordance with Good Publication Practice guidelines."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002746",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Dana-Farber Cancer Institute"},
                                {"$": "Harvard Medical School"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002746"},
                                {"@afid": "60014334"}
                            ],
                            "state": "MA",
                            "@affiliation-instance-id": "S147020452030680X-cf08e86fcea119c21135344a3e172e07",
                            "ce:source-text": "Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jacob P",
                                "preferred-name": {
                                    "ce:given-name": "Jacob P.",
                                    "ce:initials": "J.P.",
                                    "ce:surname": "Laubach",
                                    "ce:indexed-name": "Laubach J.P."
                                },
                                "@seq": "1",
                                "@author-instance-id": "S147020452030680X-0aacdce4b22a15c492488ea8ba7b5435",
                                "ce:initials": "J.P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Laubach",
                                "@auid": "6604050395",
                                "ce:indexed-name": "Laubach J.P."
                            },
                            {
                                "ce:given-name": "Paul G",
                                "preferred-name": {
                                    "ce:given-name": "Paul G.",
                                    "ce:initials": "P.G.",
                                    "ce:surname": "Richardson",
                                    "ce:indexed-name": "Richardson P.G."
                                },
                                "@seq": "26",
                                "@author-instance-id": "S147020452030680X-2b8f8f85ea847bdaf73cab1656e25439",
                                "ce:initials": "P.G.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Richardson",
                                "@auid": "34571744900",
                                "ce:indexed-name": "Richardson P.G."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Norway",
                            "@afid": "60105037",
                            "@country": "nor",
                            "city": "Oslo",
                            "organization": [
                                {"$": "Oslo Myeloma Center"},
                                {"$": "Oslo University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60105037",
                                "@dptid": "121980342"
                            },
                            "@affiliation-instance-id": "S147020452030680X-a25efd78097ea03a6f76bb1eea6bc499",
                            "ce:source-text": "Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway",
                            "@dptid": "121980342"
                        },
                        "author": [{
                            "ce:given-name": "Fredrik",
                            "preferred-name": {
                                "ce:given-name": "Fredrik",
                                "ce:initials": "F.",
                                "ce:surname": "Schjesvold",
                                "ce:indexed-name": "Schjesvold F."
                            },
                            "@seq": "2",
                            "@author-instance-id": "S147020452030680X-a54953caf1777eb8c5a2adb3e2cf3a96",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Schjesvold",
                            "@auid": "24401832100",
                            "ce:indexed-name": "Schjesvold F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Norway",
                            "@afid": "60010348",
                            "@country": "nor",
                            "city": "Oslo",
                            "organization": [
                                {"$": "KG Jebsen Center for B Cell Malignancies"},
                                {"$": "University of Oslo"}
                            ],
                            "affiliation-id": {
                                "@afid": "60010348",
                                "@dptid": "123598859"
                            },
                            "@affiliation-instance-id": "S147020452030680X-da705080100f32103a51a572dc478560",
                            "ce:source-text": "KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway",
                            "@dptid": "123598859"
                        },
                        "author": [{
                            "ce:given-name": "Fredrik",
                            "preferred-name": {
                                "ce:given-name": "Fredrik",
                                "ce:initials": "F.",
                                "ce:surname": "Schjesvold",
                                "ce:indexed-name": "Schjesvold F."
                            },
                            "@seq": "2",
                            "@author-instance-id": "S147020452030680X-a54953caf1777eb8c5a2adb3e2cf3a96",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Schjesvold",
                            "@auid": "24401832100",
                            "ce:indexed-name": "Schjesvold F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Portugal",
                            "@afid": "60003102",
                            "@country": "prt",
                            "city": "Porto",
                            "organization": {"$": "Portuguese Institute of Oncology"},
                            "affiliation-id": {"@afid": "60003102"},
                            "@affiliation-instance-id": "S147020452030680X-b2301e25f39708d20c1f57fde9907ef3",
                            "ce:source-text": "Portuguese Institute of Oncology, Porto, Portugal"
                        },
                        "author": [{
                            "ce:given-name": "Mário",
                            "preferred-name": {
                                "ce:given-name": "Mário",
                                "ce:initials": "M.",
                                "ce:surname": "Mariz",
                                "ce:indexed-name": "Mariz M."
                            },
                            "@seq": "3",
                            "@author-instance-id": "S147020452030680X-4e0ca383c1f9ea252b48b8c9adc4aafd",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Mariz",
                            "@auid": "6507570226",
                            "ce:indexed-name": "Mariz M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Greece",
                            "@afid": "60067083",
                            "@country": "grc",
                            "city": "Athens",
                            "organization": [
                                {"$": "Department of Clinical Therapeutics"},
                                {"$": "School of Medicine"},
                                {"$": "National and Kapodistrian University of Athens"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60067083",
                                    "@dptid": "104731787"
                                },
                                {"@afid": "60028900"}
                            ],
                            "@affiliation-instance-id": "S147020452030680X-7d2925b14d5381cb50908a0a6113cee6",
                            "ce:source-text": "Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece",
                            "@dptid": "104731787"
                        },
                        "author": [{
                            "ce:given-name": "Meletios A",
                            "preferred-name": {
                                "ce:given-name": "Meletios A.",
                                "ce:initials": "M.A.",
                                "ce:surname": "Dimopoulos",
                                "ce:indexed-name": "Dimopoulos M.A."
                            },
                            "@seq": "4",
                            "@author-instance-id": "S147020452030680X-be3dc49cfd66c7b625ae1bfb32553785",
                            "ce:initials": "M.A.",
                            "@date-locked": "2022-01-19T09:31:09.841",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Dimopoulos",
                            "@auid": "55978800700",
                            "ce:indexed-name": "Dimopoulos M.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60073843",
                            "@country": "pol",
                            "city": "Warsaw",
                            "organization": {"$": "Institute of Hematology and Transfusion Medicine"},
                            "affiliation-id": {"@afid": "60073843"},
                            "@affiliation-instance-id": "S147020452030680X-7bbcdcc2bcfe6b4cf25ec569beffbfe4",
                            "ce:source-text": "Institute of Hematology and Transfusion Medicine, Warsaw, Poland"
                        },
                        "author": [{
                            "ce:given-name": "Ewa",
                            "preferred-name": {
                                "ce:given-name": "Ewa",
                                "ce:initials": "E.",
                                "ce:surname": "Lech-Maranda",
                                "ce:indexed-name": "Lech-Maranda E."
                            },
                            "@seq": "5",
                            "@author-instance-id": "S147020452030680X-183e12b68fa6b18ce2a50b89c7e73e2b",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Lech-Maranda",
                            "@auid": "6602812937",
                            "ce:indexed-name": "Lech-Maranda E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Czech Republic",
                            "@afid": "60016605",
                            "@country": "cze",
                            "city": "Prague",
                            "organization": [
                                {"$": "First Faculty of Medicine"},
                                {"$": "Charles University and General Hospital in Prague"}
                            ],
                            "affiliation-id": {
                                "@afid": "60016605",
                                "@dptid": "114669134"
                            },
                            "@affiliation-instance-id": "S147020452030680X-4034aaa867bdff6dcff2390d3dc04b18",
                            "ce:source-text": "First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic",
                            "@dptid": "114669134"
                        },
                        "author": [{
                            "ce:given-name": "Ivan",
                            "preferred-name": {
                                "ce:given-name": "Ivan",
                                "ce:initials": "I.",
                                "ce:surname": "Spicka",
                                "ce:indexed-name": "Spicka I."
                            },
                            "@seq": "6",
                            "@author-instance-id": "S147020452030680X-42b241b2525d161fa9dc0236de37b62d",
                            "ce:initials": "I.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Spicka",
                            "@auid": "7003914205",
                            "ce:indexed-name": "Spicka I."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Brazil",
                            "@afid": "107071786",
                            "@country": "bra",
                            "city": "São Paulo",
                            "organization": {"$": "São Germano Clinic"},
                            "affiliation-id": {"@afid": "107071786"},
                            "@affiliation-instance-id": "S147020452030680X-a084a674b6fafbf8f8b355fe65918f88",
                            "ce:source-text": "São Germano Clinic, São Paulo, Brazil"
                        },
                        "author": [{
                            "ce:given-name": "Vania T M",
                            "preferred-name": {
                                "ce:given-name": "Vania T.M.",
                                "ce:initials": "V.T.M.",
                                "ce:surname": "Hungria",
                                "ce:indexed-name": "Hungria V.T.M."
                            },
                            "@seq": "7",
                            "@author-instance-id": "S147020452030680X-6bcd0061d60cc52d63f4e636c71b1e80",
                            "ce:initials": "V.T.M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Hungria",
                            "@auid": "7801668222",
                            "ce:indexed-name": "Hungria V.T.M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Russian Federation",
                            "@afid": "60022695",
                            "@country": "rus",
                            "city": "Saratov",
                            "organization": {"$": "Saratov State Medical University"},
                            "affiliation-id": {"@afid": "60022695"},
                            "@affiliation-instance-id": "S147020452030680X-002d9b1a7af1db5e75f0b247a3f29854",
                            "ce:source-text": "Saratov State Medical University, Saratov, Russia"
                        },
                        "author": [{
                            "ce:given-name": "Tatiana",
                            "preferred-name": {
                                "ce:given-name": "Tatiana",
                                "ce:initials": "T.",
                                "ce:surname": "Shelekhova",
                                "ce:indexed-name": "Shelekhova T."
                            },
                            "@seq": "8",
                            "@author-instance-id": "S147020452030680X-d9eaefff69689c1f96a8f47106a6e48c",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Shelekhova",
                            "@auid": "56392857800",
                            "ce:indexed-name": "Shelekhova T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Brazil",
                            "@afid": "60008088",
                            "@country": "bra",
                            "city": "São Paulo",
                            "organization": {"$": "University of São Paulo Faculty of Medicine Hospital"},
                            "affiliation-id": {"@afid": "60008088"},
                            "@affiliation-instance-id": "S147020452030680X-96ad260776398a8958b80269028b72a9",
                            "ce:source-text": "University of São Paulo Faculty of Medicine Hospital, São Paulo, Brazil"
                        },
                        "author": [{
                            "ce:given-name": "Andre",
                            "preferred-name": {
                                "ce:given-name": "Andre",
                                "ce:initials": "A.",
                                "ce:surname": "Abdo",
                                "ce:indexed-name": "Abdo A."
                            },
                            "@seq": "9",
                            "@author-instance-id": "S147020452030680X-d4661901e34057a8fc786a96d45ff407",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Abdo",
                            "@auid": "57203286664",
                            "ce:indexed-name": "Abdo A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "address-part": "Jacobasch, Illmer, Wolf",
                            "@afid": "118307450",
                            "@country": "deu",
                            "city": "Dresden",
                            "organization": {"$": "Group practice Freiberg-Richter"},
                            "affiliation-id": {"@afid": "118307450"},
                            "@affiliation-instance-id": "S147020452030680X-20454a85f0fea58b315edb30e05fa18b",
                            "ce:source-text": "Group practice Freiberg-Richter, Jacobasch, Illmer, Wolf, Dresden, Germany"
                        },
                        "author": [{
                            "ce:given-name": "Lutz",
                            "preferred-name": {
                                "ce:given-name": "Lutz",
                                "ce:initials": "L.",
                                "ce:surname": "Jacobasch",
                                "ce:indexed-name": "Jacobasch L."
                            },
                            "@seq": "10",
                            "@author-instance-id": "S147020452030680X-50e817ef13be9aca310ef20321f62960",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Jacobasch",
                            "@auid": "56638534400",
                            "ce:indexed-name": "Jacobasch L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "S147020452030680X-22bfb0c5b2556a3f91c1efeed8eb146c",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Chantana",
                            "preferred-name": {
                                "ce:given-name": "Chantana",
                                "ce:initials": "C.",
                                "ce:surname": "Polprasert",
                                "ce:indexed-name": "Polprasert C."
                            },
                            "@seq": "11",
                            "@author-instance-id": "S147020452030680X-ec5331fbdb7cdfcac161e8a588c9353e",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Polprasert",
                            "@auid": "56601214400",
                            "ce:indexed-name": "Polprasert C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Czech Republic",
                            "@afid": "60068908",
                            "@country": "cze",
                            "city": "Ostrava",
                            "organization": [
                                {"$": "Department of Hematooncology"},
                                {"$": "University Hospital of Ostrava and Faculty of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60068908",
                                "@dptid": "113305788"
                            },
                            "@affiliation-instance-id": "S147020452030680X-b01307b98237f4a89ee72c0baf900893",
                            "ce:source-text": "Department of Hematooncology, University Hospital of Ostrava and Faculty of Medicine, Ostrava, Czech Republic",
                            "@dptid": "113305788"
                        },
                        "author": [{
                            "ce:given-name": "Roman",
                            "preferred-name": {
                                "ce:given-name": "Roman",
                                "ce:initials": "R.",
                                "ce:surname": "Hájek",
                                "ce:indexed-name": "Hájek R."
                            },
                            "@seq": "12",
                            "@author-instance-id": "S147020452030680X-a0547932c100ed2db3c761e36f942b8d",
                            "ce:initials": "R.",
                            "@date-locked": "2021-10-29T15:07:05.786",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Hájek",
                            "@auid": "57225459521",
                            "ce:indexed-name": "Hajek R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hungary",
                            "@afid": "60108571",
                            "@country": "hun",
                            "city": "Debrecen",
                            "organization": [
                                {"$": "Department of Hematology"},
                                {"$": "University of Debrecen"},
                                {"$": "Faculty of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60108571",
                                    "@dptid": "118372957"
                                },
                                {"@afid": "60004400"}
                            ],
                            "@affiliation-instance-id": "S147020452030680X-973548ba00aa29a5b3e6dda6a02ae9fa",
                            "ce:source-text": "Department of Hematology, University of Debrecen, Faculty of Medicine, Debrecen, Hungary",
                            "@dptid": "118372957"
                        },
                        "author": [{
                            "ce:given-name": "Árpád",
                            "preferred-name": {
                                "ce:given-name": "Árpád",
                                "ce:initials": "Á.",
                                "ce:surname": "Illés",
                                "ce:indexed-name": "Illés Á."
                            },
                            "@seq": "13",
                            "@author-instance-id": "S147020452030680X-3f413a5e2ba17b5ec510d41461b98862",
                            "ce:initials": "Á.",
                            "@date-locked": "2022-12-27T12:33:57.542",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Illés",
                            "@auid": "58021594000",
                            "ce:indexed-name": "Illes A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60007108",
                            "@country": "pol",
                            "city": "Wrocław",
                            "organization": {"$": "Wrocław Medical University"},
                            "affiliation-id": {"@afid": "60007108"},
                            "@affiliation-instance-id": "S147020452030680X-9c8cfc0fdceca2572b54dc29218a2bc8",
                            "ce:source-text": "Wrocław Medical University, Wrocław, Poland"
                        },
                        "author": [{
                            "ce:given-name": "Tomasz",
                            "preferred-name": {
                                "ce:given-name": "Tomasz",
                                "ce:initials": "T.",
                                "ce:surname": "Wróbel",
                                "ce:indexed-name": "Wróbel T."
                            },
                            "@seq": "14",
                            "@author-instance-id": "S147020452030680X-1e0fc75bd83ac06ca8a9c53307ca1632",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Wróbel",
                            "@auid": "57225215444",
                            "ce:indexed-name": "Wrobel T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60001576",
                            "@country": "esp",
                            "city": "Barcelona",
                            "organization": [
                                {"$": "Hematology Department"},
                                {"$": "Institut Català d'Oncologia-Hospitalet"},
                                {"$": "IDIBELL"},
                                {"$": "Universitat de Barcelona"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60001576",
                                    "@dptid": "103129485"
                                },
                                {"@afid": "60015633"},
                                {"@afid": "60025847"}
                            ],
                            "@affiliation-instance-id": "S147020452030680X-b481cc1597a9163ad04a30b6e92b6efe",
                            "ce:source-text": "Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain",
                            "@dptid": "103129485"
                        },
                        "author": [{
                            "ce:given-name": "Anna",
                            "preferred-name": {
                                "ce:given-name": "Anna",
                                "ce:initials": "A.",
                                "ce:surname": "Sureda",
                                "ce:indexed-name": "Sureda A."
                            },
                            "@seq": "15",
                            "@author-instance-id": "S147020452030680X-1b3cf96e8a23da1da9bba97c77c964bd",
                            "ce:initials": "A.",
                            "@date-locked": "2022-06-29T10:56:11.216",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Sureda",
                            "@auid": "56148330700",
                            "ce:indexed-name": "Sureda A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Turkey",
                            "@afid": "60012603",
                            "@country": "tur",
                            "city": "Ankara",
                            "organization": {"$": "Ankara University"},
                            "affiliation-id": {"@afid": "60012603"},
                            "@affiliation-instance-id": "S147020452030680X-a8f4e203ed97e18609e41fc6b9e67b69",
                            "ce:source-text": "Ankara University, Ankara, Turkey"
                        },
                        "author": [{
                            "ce:given-name": "Meral",
                            "preferred-name": {
                                "ce:given-name": "Meral",
                                "ce:initials": "M.",
                                "ce:surname": "Beksac",
                                "ce:indexed-name": "Beksac M."
                            },
                            "@seq": "16",
                            "@author-instance-id": "S147020452030680X-1d22674d0787722de91f96c04c3b06a9",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Beksac",
                            "@auid": "56924887200",
                            "ce:indexed-name": "Beksac M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Brazil",
                            "@afid": "106564520",
                            "@country": "bra",
                            "city": "Barretos",
                            "organization": {"$": "Fundacao Pio XII Barretos Cancer Hospital"},
                            "affiliation-id": {"@afid": "106564520"},
                            "@affiliation-instance-id": "S147020452030680X-9df771e5cab483eec5647a88d8e7bec2",
                            "ce:source-text": "Fundacao Pio XII Barretos Cancer Hospital, Barretos, Brazil"
                        },
                        "author": [{
                            "ce:given-name": "Iara Z",
                            "preferred-name": {
                                "ce:given-name": "Iara Z.",
                                "ce:initials": "I.Z.",
                                "ce:surname": "Gonçalves",
                                "ce:indexed-name": "Gonçalves I.Z."
                            },
                            "@seq": "17",
                            "@author-instance-id": "S147020452030680X-62640d18ae37ea81bd4b0d79fd3ae13d",
                            "ce:initials": "I.Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Gonçalves",
                            "@auid": "57221103137",
                            "ce:indexed-name": "Goncalves I.Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60030315",
                            "@country": "esp",
                            "city": "Barcelona",
                            "organization": [
                                {"$": "Department of Hematology"},
                                {"$": "IDIBAPS"},
                                {"$": "Hospital Clinic"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60030315",
                                    "@dptid": "109861345"
                                },
                                {"@afid": "60010814"}
                            ],
                            "@affiliation-instance-id": "S147020452030680X-ba5c25c47c7c6cbe5217603c2b43b060",
                            "ce:source-text": "Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain",
                            "@dptid": "109861345"
                        },
                        "author": [{
                            "ce:given-name": "Joan",
                            "preferred-name": {
                                "ce:given-name": "Joan",
                                "ce:initials": "J.",
                                "ce:surname": "Bladé",
                                "ce:indexed-name": "Bladé J."
                            },
                            "@seq": "18",
                            "@author-instance-id": "S147020452030680X-b3c81d4589e7a72920dc6498de77791d",
                            "ce:initials": "J.",
                            "@date-locked": "2022-04-26T10:16:23.511",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Bladé",
                            "@auid": "55906349600",
                            "ce:indexed-name": "Blade J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": {"$": "Mayo Clinic"},
                            "affiliation-id": {"@afid": "60005558"},
                            "state": "MN",
                            "@affiliation-instance-id": "S147020452030680X-1d3146a2aae3d981ce5d8938012bbdfa",
                            "ce:source-text": "Mayo Clinic, Rochester, MN, USA"
                        },
                        "author": [{
                            "ce:given-name": "S Vincent",
                            "preferred-name": {
                                "ce:given-name": "S. Vincent",
                                "ce:initials": "S.V.",
                                "ce:surname": "Rajkumar",
                                "ce:indexed-name": "Rajkumar S.V."
                            },
                            "@seq": "19",
                            "@author-instance-id": "S147020452030680X-935eca29ac27e9e0acf17e32931519e7",
                            "ce:initials": "S.V.",
                            "@date-locked": "2021-04-27T04:00:40.867",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Rajkumar",
                            "@auid": "7007085917",
                            "ce:indexed-name": "Rajkumar S.V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60012981",
                            "@country": "usa",
                            "city": "New York",
                            "organization": {"$": "Icahn School of Medicine at Mount Sinai"},
                            "affiliation-id": {"@afid": "60012981"},
                            "state": "NY",
                            "@affiliation-instance-id": "S147020452030680X-18407592b843c4031b5b605e25e5ed24",
                            "ce:source-text": "Icahn School of Medicine at Mount Sinai, New York, NY, USA"
                        },
                        "author": [{
                            "ce:given-name": "Ajai",
                            "preferred-name": {
                                "ce:given-name": "Ajai",
                                "ce:initials": "A.",
                                "ce:surname": "Chari",
                                "ce:indexed-name": "Chari A."
                            },
                            "@seq": "20",
                            "@author-instance-id": "S147020452030680X-b884c86bc58c6206283d8e125e9b967e",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Chari",
                            "@auid": "35267791600",
                            "ce:indexed-name": "Chari A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60002339",
                            "@country": "usa",
                            "city": "Atlanta",
                            "organization": [
                                {"$": "Winship Cancer Institute"},
                                {"$": "Emory University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002339",
                                    "@dptid": "103166843"
                                },
                                {"@afid": "60000928"}
                            ],
                            "state": "GA",
                            "@affiliation-instance-id": "S147020452030680X-3a09fc32e415a19be0aaa54c1e983e30",
                            "ce:source-text": "Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA",
                            "@dptid": "103166843"
                        },
                        "author": [{
                            "ce:given-name": "Sagar",
                            "preferred-name": {
                                "ce:given-name": "Sagar",
                                "ce:initials": "S.",
                                "ce:surname": "Lonial",
                                "ce:indexed-name": "Lonial S."
                            },
                            "@seq": "21",
                            "@author-instance-id": "S147020452030680X-32293517eaf4aca96639065e2a326824",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Lonial",
                            "@auid": "57219398628",
                            "ce:indexed-name": "Lonial S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60019578",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": {"$": "Alfred Hospital-Monash University"},
                            "affiliation-id": [
                                {"@afid": "60019578"},
                                {"@afid": "60008014"}
                            ],
                            "state": "VIC",
                            "@affiliation-instance-id": "S147020452030680X-dec812603413791528c6b0bf643c3a29",
                            "ce:source-text": "Alfred Hospital-Monash University, Melbourne, VIC, Australia"
                        },
                        "author": [{
                            "ce:given-name": "Andrew",
                            "preferred-name": {
                                "ce:given-name": "Andrew",
                                "ce:initials": "A.",
                                "ce:surname": "Spencer",
                                "ce:indexed-name": "Spencer A."
                            },
                            "@seq": "22",
                            "@author-instance-id": "S147020452030680X-f8c403e48234b32993d97fd66a0d0e92",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "DM",
                            "ce:surname": "Spencer",
                            "@auid": "7202315421",
                            "ce:indexed-name": "Spencer A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60022785",
                            "@country": "fra",
                            "city": "Paris",
                            "organization": {"$": "Bichat-Claude Bernard Hospital (Paris Nord Val de Seine University Hospitals)"},
                            "affiliation-id": {"@afid": "60022785"},
                            "@affiliation-instance-id": "S147020452030680X-d5c2c9329b52a4ee21aabed3820c5816",
                            "ce:source-text": "Bichat-Claude Bernard Hospital (Paris Nord Val de Seine University Hospitals), Paris, France"
                        },
                        "author": [{
                            "ce:given-name": "Pierre",
                            "preferred-name": {
                                "ce:given-name": "Pierre",
                                "ce:initials": "P.",
                                "ce:surname": "Maison-Blanche",
                                "ce:indexed-name": "Maison-Blanche P."
                            },
                            "@seq": "23",
                            "@author-instance-id": "S147020452030680X-8907eb9a6e0a26f3ce3bd1ed965f7c18",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Maison-Blanche",
                            "@auid": "55664875900",
                            "ce:indexed-name": "Maison-Blanche P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60025861",
                            "@country": "fra",
                            "city": "Nantes",
                            "organization": {"$": "University Hospital Hotel-Dieu"},
                            "affiliation-id": {"@afid": "60025861"},
                            "@affiliation-instance-id": "S147020452030680X-efa90f264c1c8f91862ce43007d510ec",
                            "ce:source-text": "University Hospital Hotel-Dieu, Nantes, France"
                        },
                        "author": [{
                            "ce:given-name": "Philippe",
                            "preferred-name": {
                                "ce:given-name": "Philippe",
                                "ce:initials": "P.",
                                "ce:surname": "Moreau",
                                "ce:indexed-name": "Moreau P."
                            },
                            "@seq": "24",
                            "@author-instance-id": "S147020452030680X-92a574081db310881f9891227babb37b",
                            "ce:initials": "P.",
                            "@date-locked": "2021-10-09T14:24:45.167",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Moreau",
                            "@auid": "14527450700",
                            "ce:indexed-name": "Moreau P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60032489",
                            "@date-locked": "2023-01-10T08:33:02.179",
                            "@country": "esp",
                            "city": "Pamplona",
                            "organization": [
                                {"$": "Clinica Universidad de Navarra"},
                                {"$": "Centro de Investigación Médica Aplicada"},
                                {"$": "Instituto de Investigaciones Sanitarias de Navarra"},
                                {"$": "Centro de Investigación Biomédica en Red de Cáncer"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60032489"},
                                {"@afid": "60271969"},
                                {"@afid": "60267265"},
                                {"@afid": "60033320"}
                            ],
                            "@affiliation-instance-id": "S147020452030680X-26eece8f0cb8a4f96320c0cb8e5de2b7",
                            "ce:source-text": "Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigaciones Sanitarias de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain"
                        },
                        "author": [{
                            "ce:given-name": "Jesus F",
                            "preferred-name": {
                                "ce:given-name": "Jesus F.",
                                "ce:initials": "J.F.",
                                "ce:surname": "San-Miguel",
                                "ce:indexed-name": "San-Miguel J.F."
                            },
                            "@seq": "25",
                            "@author-instance-id": "S147020452030680X-49a44267f35e1ef1b8bde46d27ce4aaa",
                            "ce:initials": "J.F.",
                            "@date-locked": "2021-08-14T11:07:06.526",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "San-Miguel",
                            "@auid": "57202475274",
                            "ce:indexed-name": "San-Miguel J.F."
                        }]
                    }
                ],
                "citation-title": "Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study",
                "abstracts": "© 2021 Elsevier LtdBackground: Improved therapeutic options are needed for patients with relapsed or relapsed and refractory multiple myeloma. Subcutaneous bortezomib has replaced intravenous bortezomib as it is associated with a more favourable toxicity profile. We investigated the activity and safety of three different dosing regimens of oral panobinostat in combination with subcutaneous bortezomib and oral dexamethasone for this indication. Methods: PANORAMA 3 is an open-label, randomised, phase 2 study being done at 71 sites (hospitals and medical centres) across 21 countries. Patients aged 18 years or older with relapsed or relapsed and refractory multiple myeloma (as per International Myeloma Working Group 2014 criteria), who had received one to four previous lines of therapy (including an immunomodulatory agent), and had an Eastern Cooperative Oncology Group performance status of 2 or lower, were randomly assigned (1:1:1) to receive oral panobinostat 20 mg three times weekly, 20 mg twice weekly, or 10 mg three times weekly, plus subcutaneous bortezomib and oral dexamethasone. All study drugs were administered in 21-day cycles. Randomisation was done by an interactive response technology provider, and stratified by number of previous treatment lines and age. The primary endpoint was overall response rate after up to eight treatment cycles (analysed in all randomly assigned patients by intention to treat). Safety analyses included all patients who received at least one dose of any study drug. No statistical comparisons between groups were planned. This trial is ongoing and registered with ClinicalTrials.gov, NCT02654990. Findings: Between April 27, 2016, and Jan 17, 2019, 248 patients were randomly assigned (82 to panobinostat 20 mg three times weekly, 83 to panobinostat 20 mg twice weekly, and 83 to 10 mg panobinostat three times weekly). Median duration of follow-up across all treatment groups was 14·7 months (IQR 7·8\u201324·1). The overall response rate after up to eight treatment cycles was 62·2% (95% CI 50·8\u201372·7; 51 of 82 patients) for the 20 mg three times weekly group, 65·1% (53·8\u201375·2; 54 of 83 patients) for the 20 mg twice weekly group, and 50·6% (39·4\u201361·8; 42 of 83 patients) for the 10 mg three times weekly group. Grade 3\u20134 adverse events occurred in 71 (91%) of 78 patients in the 20 mg three times weekly group, 69 (83%) of 83 patients in the 20 mg twice weekly group, and 60 (75%) of 80 patients in the 10 mg three times weekly group; the most common (≥20% patients in any group) grade 3\u20134 adverse events were thrombocytopenia (33 [42%] of 78, 26 [31%] of 83, and 19 [24%] of 83 patients) and neutropenia (18 [23%], 13 [16%], and six [8%]). Serious adverse events occurred in 42 (54%) of 78 patients in the 20 mg three times weekly group, 40 (48%) of 83 patients in the 20 mg twice weekly group, and 35 (44%) of 83 patients in the 10 mg three times weekly group; the most common serious adverse event (≥10% patients in any group) was pneumonia (nine [12%] of 78, ten [12%] of 83, and nine [11%] of 80 patients). There were 14 deaths during the study (five [6%] of 78 patients in the 20 mg three times weekly group, three [4%] of 83 in the 20 mg twice weekly group, and six [8%] of 80 in the 10 mg three times weekly group); none of these deaths was deemed treatment related. Interpretation: The safety profile of panobinostat 20 mg three times weekly was more favourable than in previous trials of this regimen with intravenous bortezomib, suggesting that subcutaneous bortezomib improves the tolerability of the panobinostat plus bortezomib plus dexamethasone regimen. The overall response rate was highest in the 20 mg three times weekly and 20 mg twice weekly groups, with 10 mg three times weekly best tolerated. Funding: Novartis Pharmaceuticals and Secura Bio.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "postal-code": "02115",
                        "@country": "usa",
                        "city": "Boston",
                        "organization": [
                            {"$": "Dana-Farber Cancer Institute"},
                            {"$": "Harvard Medical School"}
                        ],
                        "state": "MA"
                    },
                    "person": {
                        "ce:given-name": "Jacob P",
                        "ce:initials": "J.P.",
                        "ce:degrees": "MD",
                        "ce:surname": "Laubach",
                        "ce:indexed-name": "Laubach J.P."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.journals.elsevier.com/the-lancet-oncology/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "The Lancet Oncology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "22",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "142",
                            "@last": "154"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "The Lancet Oncology",
                    "publicationdate": {
                        "month": "01",
                        "year": "2021",
                        "date-text": "January 2021",
                        "day": "01"
                    },
                    "codencode": "LOANB",
                    "sourcetitle-abbrev": "Lancet Oncol.",
                    "@country": "gbr",
                    "issn": [
                        {
                            "$": "14745488",
                            "@type": "electronic"
                        },
                        {
                            "$": "14702045",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Lancet Publishing Group"},
                    "@srcid": "12354"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "86.9.1.2",
                                    "classification-description": "IMMUNOLOGY AND INFECTIOUS DISEASES; TUMOUR IMMUNOLOGY; Neoplasia of Immune System; Human studies"
                                },
                                {
                                    "classification-code": "87.4.1.12",
                                    "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy; Drug combinations"
                                },
                                {
                                    "classification-code": "87.5.26.3",
                                    "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Haematologic Malignancies; Multiple myeloma"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2730"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "179324-69-7"},
                                        {"$": "197730-97-5"}
                                    ],
                                    "chemical-name": "bortezomib"
                                },
                                {
                                    "cas-registry-number": "50-02-2",
                                    "chemical-name": "dexamethasone"
                                },
                                {
                                    "cas-registry-number": "404950-80-7",
                                    "chemical-name": "panobinostat"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Bortezomib"},
                                {"chemical-name": "Dexamethasone"},
                                {"chemical-name": "Panobinostat"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was sponsored by Novartis Pharmaceuticals and Secura Bio. We thank all patients who participated in the study; the investigators and research staff in participating institutions; members of the independent review committee, Peter Voorhees (Levine Cancer Institute, Charlotte, NC, USA), Hani Hassoun (Memorial Sloan Kettering Cancer Center, New York, USA), and Ken Shain (Moffitt Cancer Center, Tampa, FL, USA); and Marc Buyse, of IDDI, for biostatistics support. Medical writing support was provided by Jessica Woods and Cara Valvona of Watermeadow Medical, part of Ashfield Healthcare, Witney, UK, funded by Secura Bio, San Diego, CA, USA, in accordance with Good Publication Practice guidelines.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "Publisher",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "08",
                    "@year": "2021",
                    "@timestamp": "BST 09:04:11",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2010476758",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "633748181",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2020468226",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "930420907",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20201148499",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "33301738",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2020539534",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20203215751",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20204508562",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85098232848",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85098232848",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "633748181",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77813099",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S147020452030680X",
                    "ce:ern": "pii:S147020452030680X",
                    "ce:doi": "10.1016/S1470-2045(20)30680-X"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "28",
                "reference": [
                    {
                        "ref-fulltext": "Kumar, SK, Rajkumar, SV, Dispenzieri, A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 111 (2008), 2516\u20132520.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Improved survival in multiple myeloma and the impact of novel therapies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "41949130070",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "2516",
                                    "@last": "2520"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kumar",
                                        "ce:indexed-name": "Kumar S.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Rajkumar",
                                        "ce:indexed-name": "Rajkumar S.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dispenzieri",
                                        "ce:indexed-name": "Dispenzieri A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516\u201320."
                    },
                    {
                        "ref-fulltext": "Laubach, J, Garderet, L, Mahindra, A, et al. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group. Leukemia 30 (2016), 1005\u20131017.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84958074272",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "1005",
                                    "@last": "1017"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Laubach",
                                        "ce:indexed-name": "Laubach J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Garderet",
                                        "ce:indexed-name": "Garderet L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahindra",
                                        "ce:indexed-name": "Mahindra A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Laubach J, Garderet L, Mahindra A, et al. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group. Leukemia 2016; 30: 1005\u201317."
                    },
                    {
                        "ref-fulltext": "Kumar, SK, Lee, JH, Lahuerta, JJ, et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia 26 (2012), 149\u2013157.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84856719479",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "149",
                                    "@last": "157"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kumar",
                                        "ce:indexed-name": "Kumar S.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lahuerta",
                                        "ce:indexed-name": "Lahuerta J.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Kumar SK, Lee JH, Lahuerta JJ, et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia 2012; 26: 149\u201357."
                    },
                    {
                        "ref-fulltext": "Richardson, PG, Schlossman, RL, Alsina, M, et al. PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma. Blood 122 (2013), 2331\u20132337.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84884699420",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "122"},
                                "pagerange": {
                                    "@first": "2331",
                                    "@last": "2337"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Richardson",
                                        "ce:indexed-name": "Richardson P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Schlossman",
                                        "ce:indexed-name": "Schlossman R.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Alsina",
                                        "ce:indexed-name": "Alsina M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Richardson PG, Schlossman RL, Alsina M, et al. PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma. Blood 2013; 122: 2331\u201337."
                    },
                    {
                        "ref-fulltext": "US Food and Drug Administration. FARYDAK prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf, February, 2015. (Accessed 9 November 2020)",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "FARYDAK prescribing information"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975694586",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 9 November 2020)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "US Food and Drug Administration",
                                "ce:indexed-name": "US Food and Drug Administration"
                            }}
                        },
                        "ce:source-text": "US Food and Drug Administration. FARYDAK prescribing information. February, 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf (accessed Nov 9, 2020)."
                    },
                    {
                        "ref-fulltext": "European Medicines Agency. Farydak product characteristics. https://www.ema.europa.eu/en/medicines/human/EPAR/farydak, Sept 11, 2015. (Accessed 9 November 2020)",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/medicines/human/EPAR/farydak",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Farydak product characteristics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098206438",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 9 November 2020)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "European Medicines Agency",
                                "ce:indexed-name": "European Medicines Agency"
                            }}
                        },
                        "ce:source-text": "European Medicines Agency. Farydak product characteristics. Sept 11, 2015. https://www.ema.europa.eu/en/medicines/human/EPAR/farydak (accessed Nov 9, 2020)."
                    },
                    {
                        "ref-fulltext": "Richardson, PG, Hungria, VT, Yoon, SS, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood 127 (2016), 713\u2013721.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959357825",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "127"},
                                "pagerange": {
                                    "@first": "713",
                                    "@last": "721"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Richardson",
                                        "ce:indexed-name": "Richardson P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Hungria",
                                        "ce:indexed-name": "Hungria V.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoon",
                                        "ce:indexed-name": "Yoon S.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Richardson PG, Hungria VT, Yoon SS, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood 2016; 127: 713\u201321."
                    },
                    {
                        "ref-fulltext": "San-Miguel, JF, Hungria, VT, Yoon, SS, et al. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial. Lancet Oncol 15 (2014), 1195\u20131206.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84908133944",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "1195",
                                    "@last": "1206"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "San-Miguel",
                                        "ce:indexed-name": "San-Miguel J.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Hungria",
                                        "ce:indexed-name": "Hungria V.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoon",
                                        "ce:indexed-name": "Yoon S.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "San-Miguel JF, Hungria VT, Yoon SS, et al. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial. Lancet Oncol 2014; 15: 1195\u2013206."
                    },
                    {
                        "ref-fulltext": "Moreau, P, Pylypenko, H, Grosicki, S, et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol 12 (2011), 431\u2013440.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79955461011",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "431",
                                    "@last": "440"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Moreau",
                                        "ce:indexed-name": "Moreau P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Pylypenko",
                                        "ce:indexed-name": "Pylypenko H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Grosicki",
                                        "ce:indexed-name": "Grosicki S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Moreau P, Pylypenko H, Grosicki S, et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol 2011; 12: 431\u201340."
                    },
                    {
                        "ref-fulltext": "Mohan, M, Matin, A, Davies, FE, Update on the optimal use of bortezomib in the treatment of multiple myeloma. Cancer Manag Res 9 (2017), 51\u201363.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Update on the optimal use of bortezomib in the treatment of multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85016155870",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "51",
                                    "@last": "63"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Mohan",
                                    "ce:indexed-name": "Mohan M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Matin",
                                    "ce:indexed-name": "Matin A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Davies",
                                    "ce:indexed-name": "Davies F.E."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Manag Res"
                        },
                        "ce:source-text": "Mohan M, Matin A, Davies FE. Update on the optimal use of bortezomib in the treatment of multiple myeloma. Cancer Manag Res 2017; 9: 51\u201363."
                    },
                    {
                        "ref-fulltext": "Rajkumar, SV, Dimopoulos, MA, Palumbo, A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15 (2014), e538\u2013e548.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84908604358",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "e538",
                                    "@last": "e548"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Rajkumar",
                                        "ce:indexed-name": "Rajkumar S.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dimopoulos",
                                        "ce:indexed-name": "Dimopoulos M.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Palumbo",
                                        "ce:indexed-name": "Palumbo A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538\u201348."
                    },
                    {
                        "ref-fulltext": "Rajkumar, SV, Harousseau, JL, Durie, B, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood 117 (2011), 4691\u20134695.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79955977910",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "117"},
                                "pagerange": {
                                    "@first": "4691",
                                    "@last": "4695"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Rajkumar",
                                        "ce:indexed-name": "Rajkumar S.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Harousseau",
                                        "ce:indexed-name": "Harousseau J.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Durie",
                                        "ce:indexed-name": "Durie B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Rajkumar SV, Harousseau JL, Durie B, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood 2011; 117: 4691\u201395."
                    },
                    {
                        "ref-fulltext": "Dimopoulos, MA, Jakubowiak, AJ, McCarthy, PL, et al. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J, 10, 2020, 17.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079336776",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "17"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dimopoulos",
                                        "ce:indexed-name": "Dimopoulos M.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jakubowiak",
                                        "ce:indexed-name": "Jakubowiak A.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.L.",
                                        "@_fa": "true",
                                        "ce:surname": "McCarthy",
                                        "ce:indexed-name": "McCarthy P.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J"
                        },
                        "ce:source-text": "Dimopoulos MA, Jakubowiak AJ, McCarthy PL, et al. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J 2020; 10: 17."
                    },
                    {
                        "ref-fulltext": "Mithraprabhu, S, Kalff, A, Gartlan, KH, et al. Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma. Br J Haematol, 2020 published online Sept 8. https://doi.org/10.1111/bjh.17080.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/bjh.17080",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85091012021",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "published online Sept 8.",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mithraprabhu",
                                        "ce:indexed-name": "Mithraprabhu S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kalff",
                                        "ce:indexed-name": "Kalff A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gartlan",
                                        "ce:indexed-name": "Gartlan K.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Mithraprabhu S, Kalff A, Gartlan KH, et al. Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma. Br J Haematol 2020; published online Sept 8. https://doi.org/10.1111/bjh.17080."
                    },
                    {
                        "ref-fulltext": "Jakubowiak, A, Offidani, M, Pégourie, B, et al. Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. Blood 127 (2016), 2833\u20132840.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84974633304",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "127"},
                                "pagerange": {
                                    "@first": "2833",
                                    "@last": "2840"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Jakubowiak",
                                        "ce:indexed-name": "Jakubowiak A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Offidani",
                                        "ce:indexed-name": "Offidani M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Pégourie",
                                        "ce:indexed-name": "Pegourie B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Jakubowiak A, Offidani M, Pégourie B, et al. Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. Blood 2016; 127: 2833\u201340."
                    },
                    {
                        "ref-fulltext": "Richardson, PG, Oriol, A, Beksac, M, et al. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. Lancet Oncol 20 (2019), 781\u2013794.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067190733",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "781",
                                    "@last": "794"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Richardson",
                                        "ce:indexed-name": "Richardson P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Oriol",
                                        "ce:indexed-name": "Oriol A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Beksac",
                                        "ce:indexed-name": "Beksac M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Richardson PG, Oriol A, Beksac M, et al. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. Lancet Oncol 2019; 20: 781\u201394."
                    },
                    {
                        "ref-fulltext": "Richardson, PG, San Miguel, JF, Moreau, P, et al. Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting. Blood Cancer J, 8, 2018, 109.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056258887",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "109"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Richardson",
                                        "ce:indexed-name": "Richardson P.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "San Miguel",
                                        "ce:indexed-name": "San Miguel J.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Moreau",
                                        "ce:indexed-name": "Moreau P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Cancer J"
                        },
                        "ce:source-text": "Richardson PG, San Miguel JF, Moreau P, et al. Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting. Blood Cancer J 2018; 8: 109."
                    },
                    {
                        "ref-fulltext": "Richardson, PG, Harvey, RD, Laubach, JP, Moreau, P, Lonial, S, San-Miguel, JF, Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomes. Expert Rev Clin Pharmacol 9 (2016), 35\u201348.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84949090584",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "35",
                                    "@last": "48"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Richardson",
                                    "ce:indexed-name": "Richardson P.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Harvey",
                                    "ce:indexed-name": "Harvey R.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Laubach",
                                    "ce:indexed-name": "Laubach J.P."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Moreau",
                                    "ce:indexed-name": "Moreau P."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lonial",
                                    "ce:indexed-name": "Lonial S."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "J.F.",
                                    "@_fa": "true",
                                    "ce:surname": "San-Miguel",
                                    "ce:indexed-name": "San-Miguel J.F."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Clin Pharmacol"
                        },
                        "ce:source-text": "Richardson PG, Harvey RD, Laubach JP, Moreau P, Lonial S, San-Miguel JF. Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomes. Expert Rev Clin Pharmacol 2016; 9: 35\u201348."
                    },
                    {
                        "ref-fulltext": "Hideshima, T, Richardson, PG, Anderson, KC, Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma. Mol Cancer Ther 10 (2011), 2034\u20132042.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "81055149914",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "2034",
                                    "@last": "2042"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Hideshima",
                                    "ce:indexed-name": "Hideshima T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Richardson",
                                    "ce:indexed-name": "Richardson P.G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Anderson",
                                    "ce:indexed-name": "Anderson K.C."
                                }
                            ]},
                            "ref-sourcetitle": "Mol Cancer Ther"
                        },
                        "ce:source-text": "Hideshima T, Richardson PG, Anderson KC. Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma. Mol Cancer Ther 2011; 10: 2034\u201342."
                    },
                    {
                        "ref-fulltext": "Laubach, JP, Tuchman, SA, Rosenblatt, JM, et al. Phase I, open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. June 12, 2020, European Haematology Association EP953 (abstr).",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Phase I, open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098159871",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "European Haematology Association EP953 (abstr).",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Laubach",
                                        "ce:indexed-name": "Laubach J.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Tuchman",
                                        "ce:indexed-name": "Tuchman S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rosenblatt",
                                        "ce:indexed-name": "Rosenblatt J.M."
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Laubach JP, Tuchman SA, Rosenblatt JM, et al. Phase I, open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. European Haematology Association; June 12, 2020. EP953 (abstr)."
                    },
                    {
                        "ref-fulltext": "Berdeja, JG, Hart, LL, Mace, JR, et al. Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma. Haematologica 100 (2015), 670\u2013676.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929152720",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "100"},
                                "pagerange": {
                                    "@first": "670",
                                    "@last": "676"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Berdeja",
                                        "ce:indexed-name": "Berdeja J.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hart",
                                        "ce:indexed-name": "Hart L.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Mace",
                                        "ce:indexed-name": "Mace J.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haematologica"
                        },
                        "ce:source-text": "Berdeja JG, Hart LL, Mace JR, et al. Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma. Haematologica 2015; 100: 670\u201376."
                    },
                    {
                        "ref-fulltext": "Chari, A, Cho, HJ, Dhadwal, A, et al. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv 1 (2017), 1575\u20131583.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041306605",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "1575",
                                    "@last": "1583"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chari",
                                        "ce:indexed-name": "Chari A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho H.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dhadwal",
                                        "ce:indexed-name": "Dhadwal A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Chari A, Cho HJ, Dhadwal A, et al. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv 2017; 1: 1575\u201383."
                    },
                    {
                        "ref-fulltext": "Popat, R, Brown, SR, Flanagan, L, et al. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. Lancet Haematol 3 (2016), e572\u2013e580.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84997820914",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "e572",
                                    "@last": "e580"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Popat",
                                        "ce:indexed-name": "Popat R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Brown",
                                        "ce:indexed-name": "Brown S.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Flanagan",
                                        "ce:indexed-name": "Flanagan L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Haematol"
                        },
                        "ce:source-text": "Popat R, Brown SR, Flanagan L, et al. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. Lancet Haematol 2016; 3: e572\u201380."
                    },
                    {
                        "ref-fulltext": "Dimopoulos, MA, Dytfeld, D, Grosicki, S, et al. Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma. N Engl J Med 379 (2018), 1811\u20131822.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056383130",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "379"},
                                "pagerange": {
                                    "@first": "1811",
                                    "@last": "1822"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dimopoulos",
                                        "ce:indexed-name": "Dimopoulos M.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dytfeld",
                                        "ce:indexed-name": "Dytfeld D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Grosicki",
                                        "ce:indexed-name": "Grosicki S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Dimopoulos MA, Dytfeld D, Grosicki S, et al. Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma. N Engl J Med 2018; 379: 1811\u201322."
                    },
                    {
                        "ref-fulltext": "Attal, M, Richardson, PG, Rajkumar, SV, et al. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. Lancet 394 (2019), 2096\u20132107.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076003168",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "394"},
                                "pagerange": {
                                    "@first": "2096",
                                    "@last": "2107"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Attal",
                                        "ce:indexed-name": "Attal M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Richardson",
                                        "ce:indexed-name": "Richardson P.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Rajkumar",
                                        "ce:indexed-name": "Rajkumar S.V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Attal M, Richardson PG, Rajkumar SV, et al. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. Lancet 2019; 394: 2096\u2013107."
                    },
                    {
                        "ref-fulltext": "Chari, A, Suvannasankha, A, Fay, JW, et al. Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Blood 130 (2017), 974\u2013981.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028453660",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "130"},
                                "pagerange": {
                                    "@first": "974",
                                    "@last": "981"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Chari",
                                        "ce:indexed-name": "Chari A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Suvannasankha",
                                        "ce:indexed-name": "Suvannasankha A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Fay",
                                        "ce:indexed-name": "Fay J.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Chari A, Suvannasankha A, Fay JW, et al. Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Blood 2017; 130: 974\u201381."
                    },
                    {
                        "ref-fulltext": "Siegel, DS, Schiller, GJ, Samaras, C, et al. Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment. Leukemia, 2020 published online May 6. https://doi.org/10.1038/s41375-020-0813-1.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41375-020-0813-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085142180",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "published online May 6.",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siegel",
                                        "ce:indexed-name": "Siegel D.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Schiller",
                                        "ce:indexed-name": "Schiller G.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Samaras",
                                        "ce:indexed-name": "Samaras C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Siegel DS, Schiller GJ, Samaras C, et al. Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment. Leukemia 2020; published online May 6. https://doi.org/10.1038/s41375-020-0813-1."
                    },
                    {
                        "ref-fulltext": "Plesner, T, van de Donk, N, Richardson, PG, Controversy in the use of CD38 antibody for treatment of myeloma: is high CD38 expression good or bad?. Cells, 9, 2020, 378.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Controversy in the use of CD38 antibody for treatment of myeloma: is high CD38 expression good or bad?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084339408",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "378"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Plesner",
                                    "ce:indexed-name": "Plesner T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "van de Donk",
                                    "ce:indexed-name": "van de Donk N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Richardson",
                                    "ce:indexed-name": "Richardson P.G."
                                }
                            ]},
                            "ref-sourcetitle": "Cells"
                        },
                        "ce:source-text": "Plesner T, van de Donk N, Richardson PG. Controversy in the use of CD38 antibody for treatment of myeloma: is high CD38 expression good or bad? Cells 2020; 9: 378."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Debrecen",
            "@id": "60108571",
            "affilname": "Általános Orvostudományi Kar",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108571",
            "affiliation-country": "Hungary"
        },
        {
            "affiliation-city": "Oslo",
            "@id": "60105037",
            "affilname": "Oslo Universitetssykehus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105037",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Warsaw",
            "@id": "60073843",
            "affilname": "Institute of Haematology and Transfusion Medicine, Warsaw",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073843",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Ostrava",
            "@id": "60068908",
            "affilname": "University Hospital in Ostrava",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068908",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60067083",
            "affilname": "School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60067083",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Pamplona",
            "@id": "60032489",
            "affilname": "The Cima Universidad de Navarra",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032489",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60030315",
            "affilname": "Hospital Clinic Barcelona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030315",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nantes",
            "@id": "60025861",
            "affilname": "Hôtel Dieu CHU de Nantes",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025861",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Paris",
            "@id": "60022785",
            "affilname": "Hôpital Bichat-Claude-Bernard AP-HP",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022785",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Saratov",
            "@id": "60022695",
            "affilname": "Saratov State Medical University named after V. I. Razumovsky",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022695",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60019578",
            "affilname": "Monash University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Prague",
            "@id": "60016605",
            "affilname": "Charles University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "New York",
            "@id": "60012981",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Ankara",
            "@id": "60012603",
            "affilname": "Ankara Üniversitesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012603",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Oslo",
            "@id": "60010348",
            "affilname": "Universitetet i Oslo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010348",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "60008088",
            "affilname": "Universidade de São Paulo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Wroclaw",
            "@id": "60007108",
            "affilname": "Wroclaw Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007108",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Porto",
            "@id": "60003102",
            "affilname": "Instituto Portugues de Oncologia de Francisco Gentil Porto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003102",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60002339",
            "affilname": "Emory University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60001576",
            "affilname": "Universitat de Barcelona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001576",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Dresden",
            "@id": "118307450",
            "affilname": "BAG Freiberg-Richter",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118307450",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "107071786",
            "affilname": "Clínica São Germano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107071786",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Barretos",
            "@id": "106564520",
            "affilname": "Hospital do Câncer de Barretos. Fundação Pio XII (FP)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106564520",
            "affiliation-country": "Brazil"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85098232848",
        "dc:description": "Background: Improved therapeutic options are needed for patients with relapsed or relapsed and refractory multiple myeloma. Subcutaneous bortezomib has replaced intravenous bortezomib as it is associated with a more favourable toxicity profile. We investigated the activity and safety of three different dosing regimens of oral panobinostat in combination with subcutaneous bortezomib and oral dexamethasone for this indication. Methods: PANORAMA 3 is an open-label, randomised, phase 2 study being done at 71 sites (hospitals and medical centres) across 21 countries. Patients aged 18 years or older with relapsed or relapsed and refractory multiple myeloma (as per International Myeloma Working Group 2014 criteria), who had received one to four previous lines of therapy (including an immunomodulatory agent), and had an Eastern Cooperative Oncology Group performance status of 2 or lower, were randomly assigned (1:1:1) to receive oral panobinostat 20 mg three times weekly, 20 mg twice weekly, or 10 mg three times weekly, plus subcutaneous bortezomib and oral dexamethasone. All study drugs were administered in 21-day cycles. Randomisation was done by an interactive response technology provider, and stratified by number of previous treatment lines and age. The primary endpoint was overall response rate after up to eight treatment cycles (analysed in all randomly assigned patients by intention to treat). Safety analyses included all patients who received at least one dose of any study drug. No statistical comparisons between groups were planned. This trial is ongoing and registered with ClinicalTrials.gov, NCT02654990. Findings: Between April 27, 2016, and Jan 17, 2019, 248 patients were randomly assigned (82 to panobinostat 20 mg three times weekly, 83 to panobinostat 20 mg twice weekly, and 83 to 10 mg panobinostat three times weekly). Median duration of follow-up across all treatment groups was 14·7 months (IQR 7·8\u201324·1). The overall response rate after up to eight treatment cycles was 62·2% (95% CI 50·8\u201372·7; 51 of 82 patients) for the 20 mg three times weekly group, 65·1% (53·8\u201375·2; 54 of 83 patients) for the 20 mg twice weekly group, and 50·6% (39·4\u201361·8; 42 of 83 patients) for the 10 mg three times weekly group. Grade 3\u20134 adverse events occurred in 71 (91%) of 78 patients in the 20 mg three times weekly group, 69 (83%) of 83 patients in the 20 mg twice weekly group, and 60 (75%) of 80 patients in the 10 mg three times weekly group; the most common (≥20% patients in any group) grade 3\u20134 adverse events were thrombocytopenia (33 [42%] of 78, 26 [31%] of 83, and 19 [24%] of 83 patients) and neutropenia (18 [23%], 13 [16%], and six [8%]). Serious adverse events occurred in 42 (54%) of 78 patients in the 20 mg three times weekly group, 40 (48%) of 83 patients in the 20 mg twice weekly group, and 35 (44%) of 83 patients in the 10 mg three times weekly group; the most common serious adverse event (≥10% patients in any group) was pneumonia (nine [12%] of 78, ten [12%] of 83, and nine [11%] of 80 patients). There were 14 deaths during the study (five [6%] of 78 patients in the 20 mg three times weekly group, three [4%] of 83 in the 20 mg twice weekly group, and six [8%] of 80 in the 10 mg three times weekly group); none of these deaths was deemed treatment related. Interpretation: The safety profile of panobinostat 20 mg three times weekly was more favourable than in previous trials of this regimen with intravenous bortezomib, suggesting that subcutaneous bortezomib improves the tolerability of the panobinostat plus bortezomib plus dexamethasone regimen. The overall response rate was highest in the 20 mg three times weekly and 20 mg twice weekly groups, with 10 mg three times weekly best tolerated. Funding: Novartis Pharmaceuticals and Secura Bio.",
        "pubmed-id": "33301738",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85098232848",
        "dc:creator": {"author": [{
            "ce:given-name": "Jacob P",
            "preferred-name": {
                "ce:given-name": "Jacob P.",
                "ce:initials": "J.P.",
                "ce:surname": "Laubach",
                "ce:indexed-name": "Laubach J.P."
            },
            "@seq": "1",
            "ce:initials": "J.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:degrees": "MD",
            "ce:surname": "Laubach",
            "@auid": "6604050395",
            "author-url": "https://api.elsevier.com/content/author/author_id/6604050395",
            "ce:indexed-name": "Laubach J.P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85098232848"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85098232848&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85098232848&origin=inward"
            }
        ],
        "source-id": "12354",
        "pii": "S147020452030680X",
        "citedby-count": "36",
        "prism:volume": "22",
        "subtype": "ar",
        "dc:title": "Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study",
        "openaccess": "0",
        "prism:issn": "14745488 14702045",
        "publishercopyright": "© 2021 Elsevier Ltd",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "The Lancet Oncology",
        "prism:pageRange": "142-154",
        "prism:endingPage": "154",
        "openaccessFlag": "false",
        "prism:doi": "10.1016/S1470-2045(20)30680-X",
        "prism:startingPage": "142",
        "dc:identifier": "SCOPUS_ID:85098232848",
        "dc:publisher": "Lancet Publishing Group"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Administration, Oral",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Bortezomib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Dexamethasone",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Disease Progression",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Administration Schedule",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Multiple Myeloma",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Panobinostat",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Progression-Free Survival",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Time Factors",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Oncology",
        "@code": "2730",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Jacob P",
            "preferred-name": {
                "ce:given-name": "Jacob P.",
                "ce:initials": "J.P.",
                "ce:surname": "Laubach",
                "ce:indexed-name": "Laubach J.P."
            },
            "@seq": "1",
            "ce:initials": "J.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:degrees": "MD",
            "ce:surname": "Laubach",
            "@auid": "6604050395",
            "author-url": "https://api.elsevier.com/content/author/author_id/6604050395",
            "ce:indexed-name": "Laubach J.P."
        },
        {
            "ce:given-name": "Fredrik",
            "preferred-name": {
                "ce:given-name": "Fredrik",
                "ce:initials": "F.",
                "ce:surname": "Schjesvold",
                "ce:indexed-name": "Schjesvold F."
            },
            "@seq": "2",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60105037",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105037"
                },
                {
                    "@id": "60010348",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010348"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Schjesvold",
            "@auid": "24401832100",
            "author-url": "https://api.elsevier.com/content/author/author_id/24401832100",
            "ce:indexed-name": "Schjesvold F."
        },
        {
            "ce:given-name": "Mário",
            "preferred-name": {
                "ce:given-name": "Mário",
                "ce:initials": "M.",
                "ce:surname": "Mariz",
                "ce:indexed-name": "Mariz M."
            },
            "@seq": "3",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60003102",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003102"
            },
            "ce:degrees": "MD",
            "ce:surname": "Mariz",
            "@auid": "6507570226",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507570226",
            "ce:indexed-name": "Mariz M."
        },
        {
            "ce:given-name": "Meletios A",
            "preferred-name": {
                "ce:given-name": "Meletios A.",
                "ce:initials": "M.A.",
                "ce:surname": "Dimopoulos",
                "ce:indexed-name": "Dimopoulos M.A."
            },
            "@seq": "4",
            "ce:initials": "M.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60067083",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60067083"
            },
            "ce:degrees": "MD",
            "ce:surname": "Dimopoulos",
            "@auid": "55978800700",
            "author-url": "https://api.elsevier.com/content/author/author_id/55978800700",
            "ce:indexed-name": "Dimopoulos M.A."
        },
        {
            "ce:given-name": "Ewa",
            "preferred-name": {
                "ce:given-name": "Ewa",
                "ce:initials": "E.",
                "ce:surname": "Lech-Maranda",
                "ce:indexed-name": "Lech-Maranda E."
            },
            "@seq": "5",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073843",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073843"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Lech-Maranda",
            "@auid": "6602812937",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602812937",
            "ce:indexed-name": "Lech-Maranda E."
        },
        {
            "ce:given-name": "Ivan",
            "preferred-name": {
                "ce:given-name": "Ivan",
                "ce:initials": "I.",
                "ce:surname": "Spicka",
                "ce:indexed-name": "Spicka I."
            },
            "@seq": "6",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016605",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605"
            },
            "ce:degrees": "MD",
            "ce:surname": "Spicka",
            "@auid": "7003914205",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003914205",
            "ce:indexed-name": "Spicka I."
        },
        {
            "ce:given-name": "Vania T M",
            "preferred-name": {
                "ce:given-name": "Vania T.M.",
                "ce:initials": "V.T.M.",
                "ce:surname": "Hungria",
                "ce:indexed-name": "Hungria V.T.M."
            },
            "@seq": "7",
            "ce:initials": "V.T.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "107071786",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107071786"
            },
            "ce:degrees": "MD",
            "ce:surname": "Hungria",
            "@auid": "7801668222",
            "author-url": "https://api.elsevier.com/content/author/author_id/7801668222",
            "ce:indexed-name": "Hungria V.T.M."
        },
        {
            "ce:given-name": "Tatiana",
            "preferred-name": {
                "ce:given-name": "Tatiana",
                "ce:initials": "T.",
                "ce:surname": "Shelekhova",
                "ce:indexed-name": "Shelekhova T."
            },
            "@seq": "8",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022695",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022695"
            },
            "ce:degrees": "MD",
            "ce:surname": "Shelekhova",
            "@auid": "56392857800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56392857800",
            "ce:indexed-name": "Shelekhova T."
        },
        {
            "ce:given-name": "Andre",
            "preferred-name": {
                "ce:given-name": "Andre",
                "ce:initials": "A.",
                "ce:surname": "Abdo",
                "ce:indexed-name": "Abdo A."
            },
            "@seq": "9",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008088",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088"
            },
            "ce:degrees": "MD",
            "ce:surname": "Abdo",
            "@auid": "57203286664",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203286664",
            "ce:indexed-name": "Abdo A."
        },
        {
            "ce:given-name": "Lutz",
            "preferred-name": {
                "ce:given-name": "Lutz",
                "ce:initials": "L.",
                "ce:surname": "Jacobasch",
                "ce:indexed-name": "Jacobasch L."
            },
            "@seq": "10",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "118307450",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118307450"
            },
            "ce:degrees": "MD",
            "ce:surname": "Jacobasch",
            "@auid": "56638534400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56638534400",
            "ce:indexed-name": "Jacobasch L."
        },
        {
            "ce:given-name": "Chantana",
            "preferred-name": {
                "ce:given-name": "Chantana",
                "ce:initials": "C.",
                "ce:surname": "Polprasert",
                "ce:indexed-name": "Polprasert C."
            },
            "@seq": "11",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD",
            "ce:surname": "Polprasert",
            "@auid": "56601214400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56601214400",
            "ce:indexed-name": "Polprasert C."
        },
        {
            "ce:given-name": "Roman",
            "preferred-name": {
                "ce:given-name": "Roman",
                "ce:initials": "R.",
                "ce:surname": "Hájek",
                "ce:indexed-name": "Hájek R."
            },
            "@seq": "12",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068908",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068908"
            },
            "ce:degrees": "MD",
            "ce:surname": "Hájek",
            "@auid": "57225459521",
            "author-url": "https://api.elsevier.com/content/author/author_id/57225459521",
            "ce:indexed-name": "Hajek R."
        },
        {
            "ce:given-name": "Árpád",
            "preferred-name": {
                "ce:given-name": "Árpád",
                "ce:initials": "Á.",
                "ce:surname": "Illés",
                "ce:indexed-name": "Illés Á."
            },
            "@seq": "13",
            "ce:initials": "Á.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60108571",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108571"
            },
            "ce:degrees": "MD",
            "ce:surname": "Illés",
            "@auid": "58021594000",
            "author-url": "https://api.elsevier.com/content/author/author_id/58021594000",
            "ce:indexed-name": "Illes A."
        },
        {
            "ce:given-name": "Tomasz",
            "preferred-name": {
                "ce:given-name": "Tomasz",
                "ce:initials": "T.",
                "ce:surname": "Wróbel",
                "ce:indexed-name": "Wróbel T."
            },
            "@seq": "14",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007108",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007108"
            },
            "ce:degrees": "MD",
            "ce:surname": "Wróbel",
            "@auid": "57225215444",
            "author-url": "https://api.elsevier.com/content/author/author_id/57225215444",
            "ce:indexed-name": "Wrobel T."
        },
        {
            "ce:given-name": "Anna",
            "preferred-name": {
                "ce:given-name": "Anna",
                "ce:initials": "A.",
                "ce:surname": "Sureda",
                "ce:indexed-name": "Sureda A."
            },
            "@seq": "15",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60001576",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001576"
            },
            "ce:degrees": "MD",
            "ce:surname": "Sureda",
            "@auid": "56148330700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56148330700",
            "ce:indexed-name": "Sureda A."
        },
        {
            "ce:given-name": "Meral",
            "preferred-name": {
                "ce:given-name": "Meral",
                "ce:initials": "M.",
                "ce:surname": "Beksac",
                "ce:indexed-name": "Beksac M."
            },
            "@seq": "16",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012603",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012603"
            },
            "ce:degrees": "MD",
            "ce:surname": "Beksac",
            "@auid": "56924887200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56924887200",
            "ce:indexed-name": "Beksac M."
        },
        {
            "ce:given-name": "Iara Z",
            "preferred-name": {
                "ce:given-name": "Iara Z.",
                "ce:initials": "I.Z.",
                "ce:surname": "Gonçalves",
                "ce:indexed-name": "Gonçalves I.Z."
            },
            "@seq": "17",
            "ce:initials": "I.Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "106564520",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106564520"
            },
            "ce:degrees": "MD",
            "ce:surname": "Gonçalves",
            "@auid": "57221103137",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221103137",
            "ce:indexed-name": "Goncalves I.Z."
        },
        {
            "ce:given-name": "Joan",
            "preferred-name": {
                "ce:given-name": "Joan",
                "ce:initials": "J.",
                "ce:surname": "Bladé",
                "ce:indexed-name": "Bladé J."
            },
            "@seq": "18",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60030315",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030315"
            },
            "ce:degrees": "MD",
            "ce:surname": "Bladé",
            "@auid": "55906349600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55906349600",
            "ce:indexed-name": "Blade J."
        },
        {
            "ce:given-name": "S Vincent",
            "preferred-name": {
                "ce:given-name": "S. Vincent",
                "ce:initials": "S.V.",
                "ce:surname": "Rajkumar",
                "ce:indexed-name": "Rajkumar S.V."
            },
            "@seq": "19",
            "ce:initials": "S.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Rajkumar",
            "@auid": "7007085917",
            "author-url": "https://api.elsevier.com/content/author/author_id/7007085917",
            "ce:indexed-name": "Rajkumar S.V."
        },
        {
            "ce:given-name": "Ajai",
            "preferred-name": {
                "ce:given-name": "Ajai",
                "ce:initials": "A.",
                "ce:surname": "Chari",
                "ce:indexed-name": "Chari A."
            },
            "@seq": "20",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012981",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981"
            },
            "ce:degrees": "MD",
            "ce:surname": "Chari",
            "@auid": "35267791600",
            "author-url": "https://api.elsevier.com/content/author/author_id/35267791600",
            "ce:indexed-name": "Chari A."
        },
        {
            "ce:given-name": "Sagar",
            "preferred-name": {
                "ce:given-name": "Sagar",
                "ce:initials": "S.",
                "ce:surname": "Lonial",
                "ce:indexed-name": "Lonial S."
            },
            "@seq": "21",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002339",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339"
            },
            "ce:degrees": "MD",
            "ce:surname": "Lonial",
            "@auid": "57219398628",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219398628",
            "ce:indexed-name": "Lonial S."
        },
        {
            "ce:given-name": "Andrew",
            "preferred-name": {
                "ce:given-name": "Andrew",
                "ce:initials": "A.",
                "ce:surname": "Spencer",
                "ce:indexed-name": "Spencer A."
            },
            "@seq": "22",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60019578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578"
            },
            "ce:degrees": "DM",
            "ce:surname": "Spencer",
            "@auid": "7202315421",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202315421",
            "ce:indexed-name": "Spencer A."
        },
        {
            "ce:given-name": "Pierre",
            "preferred-name": {
                "ce:given-name": "Pierre",
                "ce:initials": "P.",
                "ce:surname": "Maison-Blanche",
                "ce:indexed-name": "Maison-Blanche P."
            },
            "@seq": "23",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022785",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022785"
            },
            "ce:degrees": "MD",
            "ce:surname": "Maison-Blanche",
            "@auid": "55664875900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55664875900",
            "ce:indexed-name": "Maison-Blanche P."
        },
        {
            "ce:given-name": "Philippe",
            "preferred-name": {
                "ce:given-name": "Philippe",
                "ce:initials": "P.",
                "ce:surname": "Moreau",
                "ce:indexed-name": "Moreau P."
            },
            "@seq": "24",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025861",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025861"
            },
            "ce:degrees": "MD",
            "ce:surname": "Moreau",
            "@auid": "14527450700",
            "author-url": "https://api.elsevier.com/content/author/author_id/14527450700",
            "ce:indexed-name": "Moreau P."
        },
        {
            "ce:given-name": "Jesus F",
            "preferred-name": {
                "ce:given-name": "Jesus F.",
                "ce:initials": "J.F.",
                "ce:surname": "San-Miguel",
                "ce:indexed-name": "San-Miguel J.F."
            },
            "@seq": "25",
            "ce:initials": "J.F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60032489",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032489"
            },
            "ce:degrees": "MD",
            "ce:surname": "San-Miguel",
            "@auid": "57202475274",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202475274",
            "ce:indexed-name": "San-Miguel J.F."
        },
        {
            "ce:given-name": "Paul G",
            "preferred-name": {
                "ce:given-name": "Paul G.",
                "ce:initials": "P.G.",
                "ce:surname": "Richardson",
                "ce:indexed-name": "Richardson P.G."
            },
            "@seq": "26",
            "ce:initials": "P.G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002746",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746"
            },
            "ce:degrees": "MD",
            "ce:surname": "Richardson",
            "@auid": "34571744900",
            "author-url": "https://api.elsevier.com/content/author/author_id/34571744900",
            "ce:indexed-name": "Richardson P.G."
        }
    ]}
}}